Global Human Liver Model Market to reach USD 4.3 billion by 2025 | CAGR: 13.8%
Global Human Liver Model Market is valued at USD 1.2 billion in 2016 is anticipated to grow USD 4.3 billion with the compounded annual growth of 13.8% over the forecast period 2017-2025.
New York 29 May 2018, As per the new research study conducted by Bizwit Research & Consulting, Global Human Liver Model industry is poised to raise USD 4.3 billion by 2025. Growth of this market counts on factors such as the growing focus on developing alternatives for animal testing models, upgradations in research funding and venture capital investments for the development of liver models, growing initiatives to increase awareness about liver organoids, and growing need for the early detection of drug toxicity renders to minimize financial loss-making expenditures due to late-stage drug failure. To view the summary or to request a sample copy of this report, please click the link mentioned below:
Global Human Liver Model Market Size Estimates and Forecasts by Type (Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models, 3D Bioprinting) and by Region (North America, Europe, Asia Pacific, and Rest of the World) 2017-2025
The industry is seeming to be fairly competitive. Some of the leading market players include. Emulate (US), Ascendance Bio (US), HIREL (US), CN Bio (UK), Organovo (US), Cyfuse Biomedical (Japan) New product launches, acquisitions, and mergers are some of the strategies adopted by the key manufacturers. Additionally, the fierce competitiveness has made these players spend in product developments to improve the customer’s requirements.
Key findings of the study:
- The North America region estimated for dominating the Human Liver Model market during the forecast period.
- North America will be the highest growing segment with respect to geographical segmentation by around XX%
- Asia PacificHuman Liver Model market is estimated to grow at the highest CAGR during the forecast period.
Bizwit Research & Consulting LLP has considered the following segments for the study:
- Liver Organoids
- 2D Models
- Animal Models
- 3D Bioprinting
- North America
- Asia Pacific
- Rest of the World